Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Industry Experts | PRODUCT CODE: 1747989

Cover Image

PUBLISHER: Industry Experts | PRODUCT CODE: 1747989

Omega-3 Polyunsaturated Fatty Acids (PUFAs) - A Global Market Overview

PUBLISHED:
PAGES: 405 Pages, 131 Charts
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Global Site License)
USD 7200

Add to Cart

Global Omega-3 Polyunsaturated Fatty Acids (PUFAs) Market Trends and Outlook

Omega-3 Polyunsaturated Fatty Acids (PUFAs) are widely recognized for their considerable health benefits. They play a crucial role in promoting cardiovascular health and are also associated with protective effects against a variety of health conditions, including cancer, birth defects, diabetes, arthritis, cognitive decline, depression, and several others. These essential fatty acids are not produced by the body in sufficient quantities and must be obtained through diet or supplements. Historically, fish oils have been the primary source for extracting Omega-3 fatty acids, particularly the long-chain varieties like EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid). However, in recent years, attention has increasingly turned toward alternative sources such as krill oil, squid oil, and oils derived from microalgae. Among these, microalgae have emerged as a particularly promising and sustainable source.

INFOGRAPHICS


The global Omega-3 PUFA ingredients market faced a tumultuous year in 2023. The market experienced pronounced volatility, largely due to significant disruptions in supply and mounting economic challenges. One of the key contributing factors was a marked decline in fish oil production, especially in Peru, which is among the world's leading suppliers. This decline was brought on by a combination of environmental and regulatory factors. The El Nino phenomenon caused shifts in ocean temperatures and altered fish migration patterns, which resulted in lower fish populations. In response, the Peruvian government not only canceled a fishing season but also imposed reduced quotas for allowable catch. These developments, coupled with broader issues such as disruptions in global supply chains, shortages of raw materials, and escalating transportation costs, severely curtailed the availability of Omega-3 ingredients and triggered a significant rise in prices.

Moving into 2024, market conditions began to stabilize. There was an improvement in fishing quotas and a recovery in fish oil production, particularly in regions affected during the previous year. These developments helped to normalize both supply and pricing levels across the market. As a result, global Omega-3 demand registered a growth of 3.8%. However, with prices softening from the elevated levels of 2023, the market's overall value declined by 9.7%, settling at US$2.23 billion. Continued interest in the health benefits of Omega-3s, combined with increasing consumer awareness and innovation in sourcing and product formulation, is expected to support ongoing growth. By the year 2030, global Omega-3 PUFAs demand is projected to reach US$2.54 billion with a compound annual growth rate (CAGR) of 2.4% over the forecast period spanning 2024 to 2030.

Omega-3 Polyunsaturated Fatty Acids (PUFAs) Regional Market Analysis

The report reviews, analyzes and projects the Omega-3 PUFAs market for global and the regional markets including North America, Europe, Asia-Pacific, South America and Rest of World for the period 2021-2030 in terms of volume (metric tons) as well as value (USD). Asia-Pacific region leads the global Omega-3 PUFAs volume market with a share of 41.7% in 2024 and is further projected to record the world fastest CAGR of 5.5% during 2024-2030 to reach 91 thousand metric tons by 2030. In terms of value, North America and Asia-Pacific led the global market with shares of 33.5% and 33.2% respectively in 2024. However, demand for Omega-3 PUFAs in North America is projected to sustain the slowest CAGR of 2.2% during the similar period.

Omega-3 Polyunsaturated Fatty Acids (PUFAs) Market Analysis by Raw Material Source

Omega-3 Polyunsaturated Fatty Acid (PUFAs) ingredients analyzed in this study include Omega-3 EPA and DHA from marine sources including fish oils, krill oils and squid oils; and algal sources. Marine oils constitute the largest raw material source for Omega-3 PUFAs globally, cornering a volume share estimated at 95% in 2024, valued at US$1.8 billion. However, algal oils are likely to emerge as the faster growing source for Omega-3 PUFAs, reaching a projected US$531.5 million in 2030 by registering a CAGR of 6.6% between 2024 and 2030.

Omega-3 Polyunsaturated Fatty Acids (PUFAs) Market Analysis by End-use Application

End use applications of Omega-3PUFAs covered in this report include dietary supplements, food & beverages, animal nutrition including aqua feed and pet food, infant nutrition, pharmaceuticals and clinical nutrition. In terms of volume, dietary supplements and animal nutrition are the two largest applications for Omega-3s globally cornering shares of 57% and 22.2% respectively in 2024. Dietary supplements again lead the value market for Omega-3 globally with US$777 million, followed by infant nutrition and pharmaceuticals in 2024. Demand for Omega-3 PUFAs in the global infant nutrition sector is projected to post the fastest 2024-2030 CAGR of 6.3% in terms of volume, reaching 20 thousand metric tons by 2030.

Omega-3 Polyunsaturated Fatty Acids (PUFAs) Market Report Scope

This global report on Omega-3 Polyunsaturated Fatty Acids (PUFAs) analyzes the global and regional markets for types (based on raw material source) and end-use applications from 2021-2030 period with projections from 2024 to 2030 in terms of volume shipments in metric tons and value in US$. In addition to providing profiles of major companies operating in this space, the latest corporate and industrial developments have been covered to offer a clear panorama of the industry.

Key Metrics
Historical Period:2021-2023
Base Year:2024
Forecast Period:2024-2030
Units:Volume consumption in Metric Tons and Value market in US$
Companies Mentioned:140+

Global Omega-3 Polyunsaturated Fatty Acids (PUFAs) Market by Geographic Region

  • North America (The United States, Canada and Mexico)
  • Europe (Germany, France, Italy, Spain, Norway, Denmark, the United Kingdom and Rest of Europe)
  • Asia-Pacific (Australia/New Zealand, China, Japan, South Korea, India and Rest of Asia-Pacific)
  • South America (Argentina, Brazil and Rest of South America)
  • Rest of World

Global Omega-3 Polyunsaturated Fatty Acids (PUFAs) Market by Type (based on Raw Material Source)

  • Marine Oil Sourced Omega-3 PUFAs (EPA and DHA containing Fish Oils, Krill Oils and Squid Oils)
  • Algal Oil Sourced Omega-3 PUFAs

Global Omega-3 Polyunsaturated Fatty Acids (PUFAs) Market by End-use Application

  • Dietary Supplements
  • Food and Beverage Fortification
  • Pet Nutrition
  • Infant Nutrition
  • Pharmaceuticals
  • Clinical Nutrition

Major Market Players:

  • Aker Biomarine AA
  • Archer Daniels Midland Company
  • Austral Group S.A.A.
  • Axplora Group GmbH
  • BASF SE
  • Berg Lipidtech AS (BLT)
  • Cellana LLC
  • Chemport, INC.
  • Croda International Plc
  • DSM-Firmenich AG
  • Epax AS
  • Evonik Nutrition & Care GmbH
  • GC Rieber VivoMega AS
  • Golden Omega SA
  • Guangdong Runke Bioengineering Co., Ltd.
  • Huatai Biopharm Inc.
  • Jiangsu Auqi Marine Biotechnology Co., Ltd.
  • KD Pharma Group SA
  • LYSI hf.
  • Nippon Suisan Kaisha, Ltd. (NISSUI)
  • OLVEA Omega Solutions (Olvea Group)
  • Omega Protein Corporation
  • Orkla ASA
  • POLARIS
  • Qualitas Health Inc. dba iwi
  • Seven Seas Ltd.
  • Sinomega Biotech Engineering Co., Ltd.
  • Solutex GC, S.L.
  • Stepan Company
  • Tasa Omega SA (Tecnologica De Alimentos SA)
  • Thai Union Group PCL
  • Wiley Companies
Product Code: NTC004

TABLE OF CONTENTS

PART A: GLOBAL MARKET PERSPECTIVE

1. INTRODUCTION

  • 1.1. Product Outline
    • 1.1.1. What is Omega-3?
      • 1.1.1.1. Fatty Acids
        • 1.1.1.1.1. Saturated Fatty Acids
        • 1.1.1.1.2. Unsaturated Fatty Acids
        • 1.1.1.1.3. Polyunsaturated Fatty Acids (PUFAs)
      • 1.1.1.2. Omega-3 Fatty Acids
        • 1.1.1.2.1. Categories of Omega-3 Fatty Acids
          • 1.1.1.2.1.1. Short Chain Omega-3 Fatty Acids
            • 1.1.1.2.1.1.1. Alpha-Linolenic Acid (ALA)
          • 1.1.1.2.1.2. Long Chain Omega-3 Fatty Acids (LC-PUFAs)
            • 1.1.1.2.1.2.1. Docosahexaenoic Acid (DHA)
            • 1.1.1.2.1.2.2. Eicosapentaenoic Acid (EPA)
    • 1.1.2. Dietary Sources of Omega-3 Fatty Acids
    • 1.1.3. Omega-3 and Its Health Benefits
      • 1.1.3.1. High Cholesterol
      • 1.1.3.2. High Blood Pressure
      • 1.1.3.3. Heart Disease
      • 1.1.3.4. Diabetes
      • 1.1.3.5. Rheumatoid Arthritis (RA)
      • 1.1.3.6. Systemic Lupus Erythematosus (SLE)
      • 1.1.3.7. Osteoporosis
      • 1.1.3.8. Depression
      • 1.1.3.9. Bipolar Disorder
      • 1.1.3.10. Schizophrenia
      • 1.1.3.11. Attention Deficit/Hyperactivity Disorder (ADHD)
      • 1.1.3.12. Cognitive Decline
      • 1.1.3.13. Skin Disorders
      • 1.1.3.14. Inflammatory Bowel Disease (IBD)
      • 1.1.3.15. Asthma
      • 1.1.3.16. Macular Degeneration
      • 1.1.3.17. Menstrual Pain
      • 1.1.3.18. Colon Cancer
      • 1.1.3.19. Breast Cancer
      • 1.1.3.20. Prostate Cancer
  • 1.2. Evolution of Raw Material Sources for Omega-3 Polyunsaturated Fatty Acids (PUFAs)
    • 1.2.1. Marine Oils
      • 1.2.1.1. Fish Oil
      • 1.2.1.2. Krill Oil
      • 1.2.1.3. Other Marine Sources
    • 1.2.2. Algae
    • 1.2.3. Plants
    • 1.2.4. To Conclude
  • 1.3. Evolution of Omega-3 Fatty Acid Ingredient Forms
    • 1.3.1. First Generation Omega-3 Forms
    • 1.3.2. Second Generation Omega-3 Forms
    • 1.3.3. Third Generation Omega-3 Forms
  • 1.4. Omega-3 PUFA Ingredient Type Analysis
    • 1.4.1. 18/12 (30% Omega-3) Fish Oils
    • 1.4.2. Cod Liver Oils
    • 1.4.3. Tuna Oils
    • 1.4.4. Salmon Oils
    • 1.4.5. Omega-3 Low Concentrate (40% to 55%) PUFAs
    • 1.4.6. Omega-3 Medium Concentrate (60% to 80%) PUFAs
    • 1.4.7. Omega-3 High Concentrate (above 85%) PUFAs
    • 1.4.8. Krill Omega-3
    • 1.4.9. Algal Omega-3
    • 1.4.10. Other Omega-3 PUFAs
  • 1.5. Omega-3 PUFA End-Use Application Analysis
    • 1.5.1. Dietary Supplements
    • 1.5.2. Animal Nutrition
    • 1.5.3. Food & Beverages
    • 1.5.4. Infant Nutrition
    • 1.5.5. Pharmaceuticals
    • 1.5.6. Clinical Nutrition
  • 1.6. Manufacturing Processes for Omega-3 Fatty Acids
    • 1.6.1. Chemistry of Omega-3 Fatty Acids
    • 1.6.2. Processing of Fish Oils
    • 1.6.3. Decontamination
    • 1.6.4. Concentration Process
    • 1.6.5. Production Technologies used for Omega-3 Fatty Acid Concentrates
      • 1.6.5.1. Chromatographic Methods
      • 1.6.5.2. Distillation Method
      • 1.6.5.3. Molecular Distillation (MD)
      • 1.6.5.4. Low-Temperature Crystallization
      • 1.6.5.5. Urea Complexation/Precipitation
      • 1.6.5.6. Enzymatic Methods
        • 1.6.5.6.1. Lipase-Catalyzed Hydrolysis
        • 1.6.5.6.2. Lipase-Catalyzed Esterification
      • 1.6.5.7. Supercritical Fluid Technology (SFT)
        • 1.6.5.7.1. Supercritical Fluid Extraction (SFE)
        • 1.6.5.7.2. Supercritical Fluid Chromatography (SFC)
    • 1.6.6. Microalgae Production
    • 1.6.7. Microalgae as Sources of n-3 LC-PUFA
    • 1.6.8. Algae Oil Extraction
    • 1.6.9. In Conclusion

2. REGULATORY LANDSCAPE FOR OMEGA-3 FATTY ACIDS WORLDWIDE

  • 2.1. Recommendations for Omega-3 Fatty Acids (EPA and DHA) Intake
  • 2.2. Health Claim Approvals
    • 2.2.1. FDA Approved Health Claims
    • 2.2.2. EFSA Approved Health Claims
    • 2.2.3. Approved Health Claims in Other Regions
      • 2.2.3.1. Canada
      • 2.2.3.2. Australia and New Zealand
      • 2.2.3.3. Japan
  • 2.3. Pharmaceutical Omega-3 Drugs Approvals
  • 2.4. Regulations and Standards for Fish oils

3. KEY MARKET TRENDS

  • 3.1. Strong Outlook for High-Concentration Omega-3s Driven by Rising Pharma and Supplement Use
  • 3.2. Docosapentaenoic Acid (DPA) Returns to the Spotlight in Omega-3 Fatty Acid Market
  • 3.3. Algae Sources Offer Immense Scope for Global Omega-3s Market
  • 3.4. Algae-Based DHA Powers Sustainable Baby Milk: Immense Growth Ahead in Infant Formula Market for Omega-3 PUFAs

4. KEY GLOBAL PLAYERS

  • 4.1. Aker Biomarine AA (Norway)
  • 4.2. Archer Daniels Midland Company (United States)
  • 4.3. Austral Group S.A.A. (Peru)
  • 4.4. Axplora Group GmbH (Germany)
  • 4.5. BASF SE (Germany)
  • 4.6. Berg Lipidtech AS (BLT) (Norway)
  • 4.7. Cellana LLC (United States)
  • 4.8. Chemport, INC. (South Korea)
  • 4.9. Croda International Plc (United Kingdom)
  • 4.10. DSM-Firmenich AG (Switzerland)
  • 4.11. Epax AS (Norway)
  • 4.12. Evonik Industries AG (Germany)
  • 4.13. GC Rieber VivoMega AS (Norway)
  • 4.14. Golden Omega SA (Chile)
  • 4.15. Guangdong Runke Bioengineering Co Ltd (China)
  • 4.16. Huatai Biopharm Inc. (China)
  • 4.17. Jiangsu Auqi Marine Biotechnology Co., Ltd. (China)
  • 4.18. KD Pharma Group SA (Switzerland)
  • 4.19. LYSI hf. (Iceland)
  • 4.20. Nippon Suisan Kaisha, Ltd. (NISSUI) (Japan)
  • 4.21. OLVEA Omega Solutions (Olvea Group) (France)
  • 4.22. Omega Protein Corporation (United States)
  • 4.23. Orkla ASA (Norway)
  • 4.24. POLARIS (France)
  • 4.25. Qualitas Health Inc. dba iwi (United States)
  • 4.26. Seven Seas Ltd (United Kingdom)
  • 4.27. Sinomega Biotech Engineering Co Ltd (China)
  • 4.28. Solutex GC, S.L. (Spain)
  • 4.29. Stepan Company (United States)
  • 4.30. Tasa Omega SA (Tecnologica De Alimentos SA) (Peru)
  • 4.31. Thai Union Group PCL (Thailand)
  • 4.32. Wiley Companies (United States)

5. KEY BUSINESS AND PRODUCT TRENDS

  • 5.1. April 2025
    • 5.1.1. Icelandirect Partners with Rbionutrix
  • 5.2. March 2025
    • 5.2.1. Innovaoleo Unveils New Product Omega 3 Star
  • 5.3. February 2025
    • 5.3.1. GC Rieber Vivo Mega to Unveil VivoSense and VivoTech at Expo West 2025
    • 5.3.2. Wiley Companies Re-launches AlaskOmega Omega-7 at Natural Products Expo West 2025
    • 5.3.3. GC Rieber VivoMega Launches new Algae 1060 TG Premium
  • 5.4. January 2025
    • 5.4.1. Arctic Biosciences and Kotler Establish Joint Venture to Target China and other SE Asian markets
    • 5.4.2. Revolutionary Boost in Sustainable Omega-3 Production from Algae
  • 5.5. December 2024
    • 5.5.1. Xinhua Pharmaceutical to Acquire NovoSana Taicang
    • 5.5.2. Nature's Bounty-R Introduces New Algae Omega-3 Supplement
  • 5.6. November 2024
    • 5.6.1. Cooke Announces Acquisition of Copeinca
    • 5.6.2. Vita Actives and Brudy Technology Partner to Launch UbiOmega
  • 5.7. October 2024
    • 5.7.1. Cellana and PhytoSmart Announce Merger
    • 5.7.2. dsm-firmenich Introduces Life'sDHA-R B54-0100, a DHA Algal Oil with Rich Sensory Appeal, This Launch Expands the Brand Life's-R Portfolio
    • 5.7.3. Vermaris Announces Plans to Expand Capacity at US Plant
    • 5.7.4. Zooca Signs Distribution Agreement with Lehvoss Group
    • 5.7.5. Groupe Berkem and Arctic Bioscience Collaborate to launch BRomega(TM)
  • 5.8. September 2024
    • 5.8.1. Natac Group Establishes Omega-3 Production plant in As Somozas
    • 5.8.2. Avanti Polar Lipids Announces Transformation to Avanti Research
  • 5.9. August 2024
    • 5.9.1. Golden Omega Signs Distribution Agreement with Benexia for the North American Market
    • 5.9.2. Evonik Chooses ChemPoint as Distribution Partner
    • 5.9.3. SourceOne and Qualitas Health Partner to Launch Microalgae Omega-3 Ingredients
  • 5.10. July 2024
    • 5.10.1. Clover Corporation Unveils new Ecuador Facility
    • 5.10.2. KD Pharma Group Introduces of KD LabServices
    • 5.10.3. Arjuna Natural Extracts Launches High-Concentrate Omega-3
    • 5.10.4. Polaris Launches Omegavie DHA 650 Qualitysilver 5
    • 5.10.5. dsm-firmenich Transfers MEG-3 business to KD Pharma Group
  • 5.11. June 2024
    • 5.11.1. Maruha Nichiro Partners with Mara Renewables to Target Algae-derived DHA Market
    • 5.11.2. GC Rieber VivoMega Disclosed the Completion of its $75m Facility Expansion
  • 5.12. May 2024
    • 5.12.1. Vermaris Amplifies Omega-3 EPA & DHA production
  • 5.13. April 2024
    • 5.13.1. Omegatex Algae Products by Solutex Receive the V-label Vegan Certification
    • 5.13.2. Berring Select Announces launch of Cod Liver Oil for Pet Food Solution
    • 5.13.3. Mara Renewables forms Strategic Partnership with Checkerspot
  • 5.14. March 2024
    • 5.14.1. Golden Omega Introduces Novel Omega-3 Concentrate based on Jack Mackerel
    • 5.14.2. Sea Nova Unveils new Omega-3 Combination Sea Alga-R
    • 5.14.3. Bioriginal Leverages Technology from POS Biosciences to Launch Sustainable Omega-3 line
    • 5.14.4. dsm-firmenich Collaborates with SCN BestCo to Develop Omega-3 Gummies
    • 5.14.5. A Study by Millennial Salmon Project Reveals that Inclusion of Algaprime(TM) DHA in Diet does not Negatively Impact Feed Quality
  • 5.15. February 2024
    • 5.15.1. Bioriginal Announces Acquisition of Food Tech Leader POS Biosciences
  • 5.16. January 2024
    • 5.16.1. Omega-3 Manufacturer Zooca Launches Zooca Sport
  • 5.17. November 2023
    • 5.17.1. Algarithm Ingredients and De Wit Speciality Oils Enter into a Distribution Partnership
    • 5.17.2. Simris Appoints Reviate LLC as Distribution Partner
  • 5.18. September 2023
    • 5.18.1. Corbion Addresses the Demand for Active Nutrition in Pet Food Industry with Launch of its Sustainable Product AlgaPrime(TM) DHA P3
    • 5.18.2. Nordic Natural Omega-3 Supplements now Available at Sam's Club Stores
    • 5.18.3. Aker BioMarine and Swisse in collaboration launch an Innovative Product under Australia's Listed Assessed Medicine Category
  • 5.19. August 2023
    • 5.19.1. Wiley's Finest Launches Algae/Ahiflower Omega-3 Gummy
  • 5.20. May 2023
    • 5.20.1. Corbion Launches New Product Line AlgaVia(TM), which Marks Company's Entry into Human Nutrition Industry
  • 5.21. March 2023
    • 5.21.1. Vita Pet Life Announces Collaboration with Bioriginal
    • 5.21.2. AlgiSys has signed a MOU Agreement with Ministry of Investment of Saudi Arabia
    • 5.21.3. Zooca and Actylis form Strategic Partnership for the European Market
    • 5.21.4. Simris Alg Announces Name Change to Simris Group
    • 5.21.5. EPAX's Next-level Distillation Technology Increases Prospect for Ultra-Concentrated Omega-3
  • 5.22. February 2023
    • 5.22.1. Grontvedt Biotech Unveils CETO3
    • 5.22.2. Algarithm Ingredients and Thai Union Ingredients Forge Multi-year Partnership
    • 5.22.3. Wiley's Finest Unveils New Product Peak DHA
  • 5.23. January 2023
    • 5.23.1. Organic Omega-3 by Solarvest Granted Patent in Brazil
    • 5.23.2. Simris Group Launches Reformulated Omega-3 product now Available in EU

6. GLOBAL MARKET OVERVIEW

  • 6.1. Global Omega-3 PUFAs Market Overview by End-use Application
    • 6.1.1. Global Omega-3 PUFAs End-use Application Market Overview by Geographic Region
      • 6.1.1.1. Dietary Supplements
      • 6.1.1.2. Animal Nutrition
      • 6.1.1.3. Food & Beverages
      • 6.1.1.4. Infant Nutrition
      • 6.1.1.5. Pharmaceuticals
      • 6.1.1.6. Clinical Nutrition
  • 6.2. Global Omega-3 PUFAs Market Overview by Raw Material Source
    • 6.2.1. Global Omega-3 PUFAs Raw Material Source Market Overview by Geographic Region
      • 6.2.1.1. Marine Omega-3 PUFAs
      • 6.2.1.2. Algal Omega-3 PUFAs
  • 6.3. Global Omega-3 PUFAs Market Overview by Ingredient Type

PART B: REGIONAL MARKET PERSPECTIVE

  • Global Omega-3 PUFAs Market Overview by Geographic Region

REGIONAL MARKET OVERVIEW

7. NORTH AMERICA

  • 7.1. North American Omega-3 PUFAs Market Overview by Geographic Region
  • 7.2. North American Omega-3 PUFAs Market Overview by Raw Material Source
  • 7.3. North American Omega-3 PUFAs Market Overview by End-Use Application
  • 7.4. Major Market Players
    • 7.4.1. Aker BioMarine Manufacturing LLC (United States)
    • 7.4.2. Algae to Omega (United States)
    • 7.4.3. Algisys, LLC (United States)
    • 7.4.4. Archer Daniels Midland Company (United States)
    • 7.4.5. ArcticSource1 LLC (United States)
    • 7.4.6. Arizona Algae Products, LLC (United States)
    • 7.4.7. Bering Select LLC (United States)
    • 7.4.8. Bioriginal (Canada)
    • 7.4.9. CAS BioSciences, LLC (United States)
    • 7.4.10. Cellana LLC (United States)
    • 7.4.11. Corbion, Inc. (United States)
    • 7.4.12. GCI Nutrients, Inc. (United States)
    • 7.4.13. Helios Corp (United States)
    • 7.4.14. Mara Renewables Corporation (Canada)
      • 7.4.14.1. Algarithm Ingredients, Inc. (Canada)
    • 7.4.15. Nordic Naturals, Inc. (United States)
    • 7.4.16. Novotech Nutraceuticals, Inc. (United States)
    • 7.4.17. Omega Protein Corporation (United States)
    • 7.4.18. Originates Inc. (United States)
    • 7.4.19. Pure Alaska Omega (United States)
    • 7.4.20. Qualitas Health Inc. dba iwi (UNITED STATES)
    • 7.4.21. Rimfrost AS (Norway)
    • 7.4.22. Solarvest Bioenergy Inc. (Canada)
    • 7.4.23. Source-Omega LLC (United States)
    • 7.4.24. SourceOne Global Partners (United States)
    • 7.4.25. Stepan Company (United States)
    • 7.4.26. The Wright Group (United States)
    • 7.4.27. Virun, Inc. (United States)
    • 7.4.28. Wiley Companies (United States)

8. EUROPE

  • 8.1. European Omega-3 PUFAs Market Overview by Geographic Region
  • 8.2. European Omega-3 PUFAs Market Overview by Raw Material Source
  • 8.3. European Omega-3 PUFAs Market Overview by End-Use Application
  • 8.4. Major Market Players
    • 8.4.1. Aker Biomarine AS (Norway)
    • 8.4.2. Algae Capital B.V. (Netherlands)
    • 8.4.3. AlgaeCytes Limited (United Kingdom)
    • 8.4.4. Anklam Extrakt GmbH (Germany)
    • 8.4.5. Arctic Bioscience AS (NORWAY)
    • 8.4.6. Axplora Group GmbH (Germany)
    • 8.4.7. BASF SE (Germany)
    • 8.4.8. Berg Lipidtech AS (BLT) (Norway)
    • 8.4.9. Bluebiotech International GmbH (Germany)
    • 8.4.10. Brudy Technology S.L. (Spain)
    • 8.4.11. Carniolus d.o.o. (Slovenia)
    • 8.4.12. Copalis (France)
    • 8.4.13. Croda International Plc (United Kingdom)
    • 8.4.14. De Wit Speciality Oils (Netherlands)
    • 8.4.15. Denomega (Orkla Health) (Norway)
    • 8.4.16. DSM-Firmenich AG (Switzerland)
    • 8.4.17. Epax AS (Norway)
    • 8.4.18. Evonik Industries AG (Germany)
    • 8.4.19. Fermentalg SA (France)
    • 8.4.20. Fortuna Oils AS (Norway)
    • 8.4.21. GC RIEBER OILS (NORWAY)
    • 8.4.22. Grontvedt Biotech (Norway)
    • 8.4.23. Henry Lamotte Oils GmbH (Germany)
    • 8.4.24. Hofseth Biocare AS (Norway)
    • 8.4.25. Huve Nutraceutical Ltd (Bulgaria)
    • 8.4.26. Impact Ingredients BV (Netherlands)
    • 8.4.27. Imperial-Oel-Import Handelsgesellschaft mbh (Germany)
    • 8.4.28. IQI B.V. (Netherlands)
    • 8.4.29. KD Pharma Group SA (Switzerland)
    • 8.4.30. Kerry Group plc (Ireland)
    • 8.4.31. LYSI hf. (Iceland)
    • 8.4.32. Margildi EHF. (Iceland)
    • 8.4.33. Minami Nutrition (Belgium)
    • 8.4.34. Mowi ASA (NORWAY)
    • 8.4.35. Natac Natural Ingredients S.L.U. - Innovaoleo (Spain)
    • 8.4.36. Noble Harvest AS (Norway)
    • 8.4.37. Norwegian Fish Oil AS (Norway)
    • 8.4.38. Nutriswiss AG (Switzerland)
    • 8.4.39. OLVEA Omega Solutions (OLVEA Group) (France)
    • 8.4.40. Omnipharm SAS (France)
    • 8.4.41. Pharma Marine AS (Norway)
    • 8.4.42. POLARIS (France)
    • 8.4.43. Progress Biotech bv (Netherlands)
    • 8.4.44. Rimfrost AS (Norway)
    • 8.4.45. Seafoodia (France)
    • 8.4.46. SEANOVA (France)
    • 8.4.47. Seven Seas Ltd (United Kingdom)
    • 8.4.48. Simris Alg AB (Sweden)
    • 8.4.49. Sochim International Spa (Italy)
    • 8.4.50. Solutex GC, S.L. (Spain)
    • 8.4.51. Stepan Lipid Nutrition (Netherlands)
    • 8.4.52. Thai Union Marine Nutrients GmbH (Germany)
    • 8.4.53. Triplenine Group A/S (Denmark)
    • 8.4.54. True Westfjords ehf (Iceland)
    • 8.4.55. Veramaris V.O.F. (Netherlands)
    • 8.4.56. Vesteraalens AS (Norway)
    • 8.4.57. Zooca (Norway)

9. ASIA-PACIFIC

  • 9.1. Asia-Pacific Omega-3 PUFAs Market Overview by Geographic Region
  • 9.2. Asia-Pacific Omega-3 PUFAs Market Overview by Raw Material Source
  • 9.3. Asia-Pacific Omega-3 PUFAs Market Overview by End-Use Application
  • 9.4. Major Market Players
    • 9.4.1. AK & MN BioFarm Co Ltd (South Korea)
    • 9.4.2. Ambe Phytoextracts Pvt. Ltd. (India)
    • 9.4.3. Arbee Biomarine Extracts Pvt Ltd. (India)
    • 9.4.4. Arjuna Natural Pvt Ltd (India)
    • 9.4.5. ATK Biotech Co., Ltd. (China)
    • 9.4.6. Avesthagen Limited (India)
    • 9.4.7. BioPlus life Sciences Pvt. Ltd. (India)
    • 9.4.8. Bizen Chemical Co Ltd (Japan)
    • 9.4.9. Blueline Foods (India) Pvt Ltd (India)
    • 9.4.10. CABIO Biotech (Wuhan) Co., Ltd. (China)
    • 9.4.11. Camlin Fine Sciences, Ltd. (India)
    • 9.4.12. Chambio Co., Ltd. (Taiwan)
    • 9.4.13. Chemport, Inc. (South Korea)
    • 9.4.14. Clover Corporation (Nu-Mega) (Australia)
    • 9.4.15. Coastal Exports Corporation (India)
    • 9.4.16. ECA Healthcare Inc (China)
    • 9.4.17. Ennature Biopharma (India Glycols Ltd) (India)
    • 9.4.18. Fenchem Biotek Ltd (China)
    • 9.4.19. Fujian High Fortune Bio-Tech Corp. (China)
    • 9.4.20. Guangdong Runke Bioengineering Co Ltd (China)
    • 9.4.21. Huatai Biopharm Inc. (China)
    • 9.4.22. Hubei Fuxing Biotechnology Co Ltd (China)
    • 9.4.23. Jiangsu Auqi Marine Biotechnology Co., Ltd. (China)
    • 9.4.24. Jiangsu Weisikang Food Sci-tech Development Co., Ltd. (China)
    • 9.4.25. K Pharmtech Co. Ltd. (South Korea)
    • 9.4.26. Kangcare Bioindustry Co., Ltd. (China)
    • 9.4.27. Kinomega Biopharm Inc. (China)
    • 9.4.28. Luhua Biomarine (Shandong) Co., Ltd (China)
    • 9.4.29. Nippon Suisan Kaisha, Ltd. (NISSUI) (Japan)
    • 9.4.30. Nisshin Pharma Inc. (Japan)
    • 9.4.31. Novosana (Taicang) Co. Ltd. (China)
    • 9.4.32. Phycoil Biotech Korea, Inc. (South Korea)
    • 9.4.33. Qingdao AlgaeNutra Biotech Co., Ltd (China)
    • 9.4.34. Qponics Limited (Australia)
    • 9.4.35. Seadragon Marine Oils Ltd (New Zealand)
    • 9.4.36. Shandong Yuwang Pharmaceutical Co., Ltd (China)
    • 9.4.37. Shangdong Kangjing Marine Biotechnology Co., Ltd (China)
    • 9.4.38. Shenzhen Qianhai Xiaozao Technology Ltd.(Lyxia) (China)
    • 9.4.39. Sinomega Biotech Engineering Co Ltd (China)
    • 9.4.40. Skuny Bioscience Co., Ltd. (China)
    • 9.4.41. Thai Union Group PCL (Thailand)
    • 9.4.42. Wuxi Xunda Marine Biological Products Co., Ltd. (China)
    • 9.4.43. Xiamen Huison Biotech Co., Ltd. (China)
    • 9.4.44. ZhongHai Ocean Technology Co., Ltd. (China)

10. SOUTH AMERICA

  • 10.1. South American Omega-3 PUFAs Market Overview by Geographic Region
  • 10.2. South American Omega-3 PUFAs Market Overview by Raw Material Source
  • 10.3. South American Omega-3 PUFAs Market Overview by End-Use Application
  • 10.4. Major Market Players
    • 10.4.1. AntarcticOmega SpA (Chile)
    • 10.4.2. Austral Group S.A.A. (Peru)
    • 10.4.3. Colpex International S.A.C (Peru)
    • 10.4.4. Corporacion Pesquera Inca S.A.C. (Peru)
    • 10.4.5. Cox & Compania S.A. (Chile)
    • 10.4.6. GIHON - Laboratorios QuImicos SRL (Argentina)
    • 10.4.7. Golden Omega SA (Chile)
    • 10.4.8. Natural Oils Chile SA (Chile)
    • 10.4.9. Naturmega SA (Colombia)
    • 10.4.10. Pesquera Camanchaca SA (Chile)
    • 10.4.11. Pesquera Diamante SA (Peru)
    • 10.4.12. Pesquera Hayduk SA (Peru)
    • 10.4.13. SPES S.A. (Chile)
    • 10.4.14. TASA Omega SA (Tecnologica De Alimentos SA) (Peru)

11. REST OF WORLD

  • 11.1. Rest of World Omega-3 PUFAs Market Overview by Raw Material Source
  • 11.2. Rest of World Omega-3 PUFAs Market Overview by End-Use Application
  • 11.3. Major Market Player
    • 11.3.1. Rbionutrix FZ LLC (United Arab Emirates)

12. OMEGA-3 PATENT LANDSCAPE

  • 12.1. Fish Oil Omega-3 Fatty Acids
  • 12.2. Algal Oil Omega-3 Fatty Acids

PART C: GUIDE TO THE INDUSTRY

  • 1. MANUFACTURERS OF OMEGA 3 INGREDIENTS
  • 2. RAW MATERIAL PRODUCERS AND EQUIPMENT SUPPLIERS
  • 3. MAJOR INGREDEINT DISTRIBUTORS
  • 4. OMEGA-3 END-USERS

PART D: ANNEXURE

  • 1. RESEARCH METHODOLOGY
  • 2. FEEDBACK

Charts & Graphs

PART A: GLOBAL MARKET PERSPECTIVE

  • Chart 1: Global Omega-3 PUFAs Market Analysis by Geographic Region (21-2030)
  • Chart 2: Global Omega-3 PUFAs Market Analysis by Raw Material Source (2021-2030)
  • Chart 3: Global Omega-3 PUFAs Market Analysis by End-use Application (2021-2030)
  • Chart 4: 2024 Snapshot for Global Omega-3 PUFAs Market Share by Ingredient Type
  • Chart 5: Global 18/12 Fish Oil Omega-3 PUFAs Market Analysis (2021-2030) - Volume in Metric Tons and Value in USD Million
  • Chart 6: Global Cod Liver Oil Omega-3 PUFAs Market Analysis (2021-2030) - Volume in Metric Tons and Value in USD Million
  • Chart 7: Global Tuna Oil Omega-3 PUFAs Market Analysis (2021-2030) - Volume in Metric Tons and Value in USD Million
  • Chart 8: Global Salmon Oil Omega-3 PUFAs Market Analysis (2021-2030) - Volume in Metric Tons and Value in USD Million
  • Chart 9: Global Low Concentrate Omega-3 PUFAs Market Analysis (2021-2030) - Volume in Metric Tons and Value in USD Million
  • Chart 10: Global Medium Concentrate Omega-3 PUFAs Market Analysis (2021-2030) - Volume in Metric Tons and Value in USD Million
  • Chart 11: Global High Concentrate Omega-3 PUFAs Market Analysis (2021-2030) - Volume in Metric Tons and Value in USD Million
  • Chart 12: Global Krill Omega-3 PUFAs Market Analysis (2021-2030) - Volume in Metric Tons and Value in USD Million
  • Chart 13: Global Algal Omega-3 PUFAs Market Analysis (2021-2030) - Volume in Metric Tons and Value in USD Million
  • Chart 14: Global Other Omega-3 PUFAs Market Analysis (2021-2030) - Volume in Metric Tons and Value in USD Million
  • Chart 15: 2024 Snapshot for Global Omega3 PUFAs Market Share by End-Use Application
  • Chart 16: Global Omega-3 PUFAs Market Analysis (2021-2030) in Dietary Supplements - Volume in Metric Tons and Value in USD Million
  • Chart 17: Global Omega-3 PUFAs Market Analysis (2021-2030) in Animal Nutrition - Volume in Metric Tons and Value in USD Million
  • Chart 18: Global Omega-3 PUFAs Market Analysis (2021-2030) in Food & Beverages - Volume in Metric Tons and Value in USD Million
  • Chart 19: Global Omega-3 PUFAs Market Analysis (2021-2030) in Infant Nutrition - Volume in Metric Tons and Value in USD Million
  • Chart 20: Global Omega-3 PUFAs Market Analysis (2021-2030) in Pharmaceuticals - Volume in Metric Tons and Value in USD Million
  • Chart 21: Global Omega-3 PUFAs Market Analysis (2021-2030) in Clinical Nutrition - Volume in Metric Tons and Value in USD Million

GLOBAL MARKET OVERVIEW

  • Chart 22: Global Omega-3 PUFAs Market Analysis (2021-2030) - Volume in Metric Tons and Value in USD Million
  • Chart 23: Global Omega-3 PUFAs Market Analysis (2021-2030) by End-use Application - Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition in Metric Tons
  • Chart 24: Glance at 2021, 2024 and 2030 Global Omega-3 PUFAs Volume Market Share (%) by End-use Application - Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition
  • Chart 25: Global Omega-3 PUFAs Market Analysis (2021-2030) by End-use Application - Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition in USD Million
  • Chart 26: Glance at 2021, 2024 and 2030 Global Omega-3 PUFAs Value Market Share (%) by End-use Application - Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition
  • Chart 27: Global Omega-3 PUFAs Market Analysis (2021-2030) in Dietary Supplements by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in Metric Tons
  • Chart 28: Glance at 2021, 2024 and 2030 Global Omega-3 PUFAs Volume Market Share (%) in Dietary Supplements by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 29: Global Omega-3 PUFAs Market Analysis (2021-2030) in Dietary Supplements by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 30: Glance at 2021, 2024 and 2030 Global Omega-3 PUFAs Value Market Share (%) in Dietary Supplements by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 31: Global Omega-3 PUFAs Market Analysis (2021-2030) in Animal Nutrition by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in Metric Tons
  • Chart 32: Glance at 2021, 2024 and 2030 Global Omega-3 PUFAs Volume Market Share (%) in Animal Nutrition by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 33: Global Omega-3 PUFAs Market Analysis (2021-2030) in Animal Nutrition by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 34: Glance at 2021, 2024 and 2030 Global Omega-3 PUFAs Value Market Share (%) in Animal Nutrition by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 35: Global Omega-3 PUFAs Market Analysis (2021-2030) in Food & Beverages by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in Metric Tons
  • Chart 36: Glance at 2021, 2024 and 2030 Global Omega-3 PUFAs Volume Market Share (%) in Food & Beverages by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 37: Global Omega-3 PUFAs Market Analysis (2021-2030) in Food & Beverages by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 38: Glance at 2021, 2024 and 2030 Global Omega-3 PUFAs Value Market Share (%) in Food & Beverages by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 39: Global Omega-3 PUFAs Market Analysis (2021-2030) in Infant Nutrition by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in Metric Tons
  • Chart 40: Glance at 2021, 2024 and 2030 Global Omega-3 PUFAs Volume Market Share (%) in Infant Nutrition by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 41: Global Omega-3 PUFAs Market Analysis (2021-2030) in Infant Nutrition by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 42: Glance at 2021, 2024 and 2030 Global Omega-3 PUFAs Value Market Share (%) in Infant Nutrition by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 43: Global Omega-3 PUFAs Market Analysis (2021-2030) in Pharmaceuticals by Geographic Region - North America, Europe and Asia-Pacific in Metric Tons
  • Chart 44: Glance at 2021, 2024 and 2030 Global Omega-3 PUFAs Volume Market Share (%) in Pharmaceuticals by Geographic Region - North America, Europe and Asia-Pacific
  • Chart 45: Global Omega-3 PUFAs Market Analysis (2021-2030) in Pharmaceuticals by Geographic Region - North America, Europe and Asia-Pacific in USD Million
  • Chart 46: Glance at 2021, 2024 and 2030 Global Omega-3 PUFAs Value Market Share (%) in Pharmaceuticals by Geographic Region - North America, Europe and Asia-Pacific
  • Chart 47: Global Omega-3 PUFAs Market Analysis (2021-2030) in Clinical Nutrition by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in Metric Tons
  • Chart 48: Glance at 2021, 2024 and 2030 Global Omega-3 PUFAs Volume Market Share (%) in Clinical Nutrition by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 49: Global Omega-3 PUFAs Market Analysis (2021-2030) in Clinical Nutrition by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 50: Glance at 2021, 2024 and 2030 Global Omega-3 PUFAs Value Market Share (%) in Clinical Nutrition by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 51: Global Omega-3 PUFAs Market Analysis (2021-2030) by Raw Material Source - Marine and Algal in Metric Tons
  • Chart 52: Glance at 2021, 2024 and 2030 Global Omega-3 PUFAs Volume Market Share (%) by Raw Material Source - Marine and Algal
  • Chart 53: Global Omega-3 PUFAs Market Analysis (2021-2030) by Raw Material Source - Marine and Algal in USD Million
  • Chart 54: Glance at 2021, 2024 and 2030 Global Omega-3 PUFAs Value Market Share (%) by Raw Material Source - Marine and Algal
  • Chart 55: Global Marine Omega-3 PUFAs Market Analysis (2021-2030) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in Metric Tons
  • Chart 56: Glance at 2021, 2024 and 2030 Global Marine Omega-3 PUFAs Volume Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 57: Global Marine Omega-3 PUFAs Market Analysis (2021-2030) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 58: Glance at 2021, 2024 and 2030 Global Marine Omega-3 PUFAs Value Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 59: Global Algal Omega-3 PUFAs Market Analysis (2021-2030) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in Metric Tons
  • Chart 60: Glance at 2021, 2024 and 2030 Global Algal Omega-3 PUFAs Volume Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 61: Global Algal Omega-3 PUFAs Market Analysis (2021-2030) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 62: Glance at 2021, 2024 and 2030 Global Algal Omega-3 PUFAs Value Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 63: Global Omega-3 PUFAs Market Analysis (2021-2030) by Ingredient Type - 18/12 Fish Oils, Tuna Oils, Cod Liver Oils, Sardine Oils, Low Concentrates (40-60%), Medium Concentrates (70-85%), High Concentrates (>85%), Krill Omega-3, Algal Omega-3 and Others in Metric Tons
  • Chart 64: Glance at 2021, 2024 and 2030 Global Omega-3 PUFAs Volume Market Share (%) by Ingredient Type - 18/12 Fish Oils, Tuna Oils, Cod Liver Oils, Sardine Oils, Low Concentrates (40-60%), Medium Concentrates (70-85%), High Concentrates (>85%), Krill Omega-3, Algal Omega-3 and Others
  • Chart 65: Global Omega-3 PUFAs Market Analysis (2021-2030) by Ingredient Type - 18/12 Fish Oils, Tuna Oils, Cod Liver Oils, Sardine Oils, Low Concentrates (40-60%), Medium Concentrates (70-85%), High Concentrates (>85%), Krill Omega-3, Algal Omega-3 and Others in USD Million
  • Chart 66: Glance at 2021, 2024 and 2030 Global Omega-3 PUFAs Value Market Share (%) by Ingredient Type - 18/12 Fish Oils, Tuna Oils, Cod Liver Oils, Sardine Oils, Low Concentrates (40-60%), Medium Concentrates (70-85%), High Concentrates (>85%), Krill Omega-3, Algal Omega-3 and Others

PART B: REGIONAL MARKET PERSPECTIVE

  • Chart 67: Global Omega-3 PUFAs Market Analysis (2021-2030) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in Metric Tons
  • Chart 68: Glance at 2021, 2024 and 2030 Global Omega-3 PUFAs Volume Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 69: Global Omega-3 PUFAs Market Analysis (2021-2030) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 70: Glance at 2021, 2024 and 2030 Global Omega-3 PUFAs Value Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World

REGIONAL MARKET OVERVIEW

NORTH AMERICA

  • Chart 71: North American Omega-3 PUFAs Market Analysis (2021-2030) - Volume in Metric Tons and Value in USD Million
  • Chart 72: North American Omega-3 PUFAs Market Analysis (2021-2030) by Geographic Region - United States, Canada and Mexico in Metric Tons
  • Chart 73: Glance at 2021, 2024 and 2030 North American Omega-3 PUFAs Volume Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 74: North American Omega-3 PUFAs Market Analysis (2021-2030) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 75: Glance at 2021, 2024 and 2030 North American Omega-3 PUFAs Value Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 76: North American Omega-3 PUFAs Market Analysis (2021-2030) by Raw Material Source - Marine and Algal in Metric Tons
  • Chart 77: Glance at 2021, 2024 and 2030 North American Omega-3 PUFAs Volume Market Share (%) by Raw Material Source - Marine and Algal
  • Chart 78: North American Omega-3 PUFAs Market Analysis (2021-2030) by Raw Material Source - Marine and Algal in USD Million
  • Chart 79: Glance at 2021, 2024 and 2030 North American Omega-3 PUFAs Value Market Share (%) by Raw Material Source - Marine and Algal
  • Chart 80: North American Omega-3 PUFAs Market Analysis (2021-2030) by End-use Application - Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition in Metric Tons
  • Chart 81: Glance at 2021, 2024 and 2030 North American Omega-3 PUFAs Volume Market Share (%) by End-use Application - Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition
  • Chart 82: North American Omega-3 PUFAs Market Analysis (2021-2030) by End-use Application - Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition in USD Million
  • Chart 83: Glance at 2021, 2024 and 2030 North American Omega-3 PUFAs Value Market Share (%) by End-use Application - Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition

EUROPE

  • Chart 84: European Omega-3 PUFAs Market Analysis (2021-2030) - Volume in Metric Tons and Value in USD Million
  • Chart 85: European Omega-3 PUFAs Market Analysis (2021-2030) by Geographic Region - Denmark, France, Germany, Italy, Norway, Spain, United Kingdom and Rest of Europe in Metric Tons
  • Chart 86: Glance at 2021, 2024 and 2030 European Omega-3 PUFAs Volume Market Share (%) by Geographic Region - Denmark, France, Germany, Italy, Norway, Spain, United Kingdom and Rest of Europe
  • Chart 87: European Omega-3 PUFAs Market Analysis (2021-2030) by Geographic Region - Denmark, France, Germany, Italy, Norway, Spain, United Kingdom and Rest of Europe in USD Million
  • Chart 88: Glance at 2021, 2024 and 2030 European Omega-3 PUFAs Value Market Share (%) by Geographic Region - Denmark, France, Germany, Italy, Norway, Spain, United Kingdom and Rest of Europe
  • Chart 89: European Omega-3 PUFAs Market Analysis (2021-2030) by Raw Material Source - Marine and Algal in Metric Tons
  • Chart 90: Glance at 2021, 2024 and 2030 European Omega-3 PUFAs Volume Market Share (%) by Raw Material Source - Marine and Algal
  • Chart 91: European Omega-3 PUFAs Market Analysis (2021-2030) by Raw Material Source - Marine and Algal in USD Million
  • Chart 92: Glance at 2021, 2024 and 2030 European Omega-3 PUFAs Value Market Share (%) by Raw Material Source - Marine and Algal
  • Chart 93: European Omega-3 PUFAs Market Analysis (2021-2030) by End-use Application - Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition in Metric Tons
  • Chart 94: Glance at 2021, 2024 and 2030 European Omega-3 PUFAs Volume Market Share (%) by End-use Application - Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition
  • Chart 95: European Omega-3 PUFAs Market Analysis (2021-2030) by End-use Application - Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition in USD Million
  • Chart 96: Glance at 2021, 2024 and 2030 European Omega-3 PUFAs Value Market Share (%) by End-use Application - Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition

ASIA-PACIFIC

  • Chart 97: Asia-Pacific Omega-3 PUFAs Market Analysis (2021-2030) - Volume in Metric Tons and Value in USD Million
  • Chart 98: Asia-Pacific Omega-3 PUFAs Market Analysis (2021-2030) by Geographic Region - Australia, China, India, Japan, South Korea and Rest of Asia-Pacific in Metric Tons
  • Chart 99: Glance at 2021, 2024 and 2030 Asia-Pacific Omega-3 PUFAs Volume Market Share (%) by Geographic Region - Australia, China, India, Japan, South Korea and Rest of Asia-Pacific
  • Chart 100: Asia-Pacific Omega-3 PUFAs Market Analysis (2021-2030) by Geographic Region - Australia, China, India, Japan, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 101: Glance at 2021, 2024 and 2030 Asia-Pacific Omega-3 PUFAs Value Market Share (%) by Geographic Region - Australia, China, India, Japan, South Korea and Rest of Asia-Pacific
  • Chart 102: Asia-Pacific Omega-3 PUFAs Market Analysis (2021-2030) by Raw Material Source - Marine and Algal in Metric Tons
  • Chart 103: Glance at 2021, 2024 and 2030 Asia-Pacific Omega-3 PUFAs Volume Market Share (%) by Raw Material Source - Marine and Algal
  • Chart 104: Asia-Pacific Omega-3 PUFAs Market Analysis (2021-2030) by Raw Material Source - Marine and Algal in USD Million
  • Chart 105: Glance at 2021, 2024 and 2030 Asia-Pacific Omega-3 PUFAs Value Market Share (%) by Raw Material Source - Marine and Algal
  • Chart 106: Asia-Pacific Omega-3 PUFAs Market Analysis (2021-2030) by End-use Application - Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition in Metric Tons
  • Chart 107: Glance at 2021, 2024 and 2030 Asia-Pacific Omega-3 PUFAs Volume Market Share (%) by End-use Application - Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition
  • Chart 108: Asia-Pacific Omega-3 PUFAs Market Analysis (2021-2030) by End-use Application - Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition in USD Million
  • Chart 109: Glance at 2021, 2024 and 2030 Asia-Pacific Omega-3 PUFAs Value Market Share (%) by End-use Application - Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition

SOUTH AMERICA

  • Chart 110: South American Omega-3 PUFAs Market Analysis (2021-2030) - Volume in Metric Tons and Value in USD Million
  • Chart 111: South American Omega-3 PUFAs Market Analysis (2021-2030) by Geographic Region - Argentina, Brazil and Rest of South America in Metric Tons
  • Chart 112: Glance at 2021, 2024 and 2030 South American Omega-3 PUFAs Volume Market Share (%) by Geographic Region - Argentina, Brazil and Rest of South America
  • Chart 113: South American Omega-3 PUFAs Market Analysis (2021-2030) by Geographic Region - Argentina, Brazil and Rest of South America in USD Million
  • Chart 114: Glance at 2021, 2024 and 2030 South American Omega-3 PUFAs Value Market Share (%) by Geographic Region - Argentina, Brazil and Rest of South America
  • Chart 115: South American Omega-3 PUFAs Market Analysis (2021-2030) by Raw Material Source - Marine and Algal in Metric Tons
  • Chart 116: Glance at 2021, 2024 and 2030 South American Omega-3 PUFAs Volume Market Share (%) by Raw Material Source - Marine and Algal
  • Chart 117: South American Omega-3 PUFAs Market Analysis (2021-2030) by Raw Material Source - Marine and Algal in USD Million
  • Chart 118: Glance at 2021, 2024 and 2030 South American Omega-3 PUFAs Value Market Share (%) by Raw Material Source - Marine and Algal
  • Chart 119: South American Omega-3 PUFAs Market Analysis (2021-2030) by End-use Application - Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition and Clinical Nutrition in Metric Tons
  • Chart 120: Glance at 2021, 2024 and 2030 South American Omega-3 PUFAs Volume Market Share (%) by End-use Application - Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition and Clinical Nutrition
  • Chart 121: South American Omega-3 PUFAs Market Analysis (2021-2030) by End-use Application - Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition and Clinical Nutrition in USD Million
  • Chart 122: Glance at 2021, 2024 and 2030 South American Omega-3 PUFAs Value Market Share (%) by End-use Application - Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition and Clinical Nutrition

REST OF WORLD

  • Chart 123: Rest of World Omega-3 PUFAs Market Analysis (2021-2030) - Volume in Metric Tons and Value in USD Million
  • Chart 124: Rest of World Omega-3 PUFAs Market Analysis (2021-2030) by Raw Material Source - Marine and Algal in Metric Tons
  • Chart 125: Glance at 2021, 2024 and 2030 Rest of World Omega-3 PUFAs Volume Market Share (%) by Raw Material Source - Marine and Algal
  • Chart 126: Rest of World Omega-3 PUFAs Market Analysis (2021-2030) by Raw Material Source - Marine and Algal in USD Million
  • Chart 127: Glance at 2021, 2024 and 2030 Rest of World Omega-3 PUFAs Value Market Share (%) by Raw Material Source - Marine and Algal
  • Chart 128: Rest of World Omega-3 PUFAs Market Analysis (2021-2030) by End-use Application - Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition and Clinical Nutrition in Metric Tons
  • Chart 129: Glance at 2021, 2024 and 2030 Rest of World Omega-3 PUFAs Volume Market Share (%) by End-use Application - Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition and Clinical Nutrition
  • Chart 130: Rest of World Omega-3 PUFAs Market Analysis (2021-2030) by End-use Application - Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition and Clinical Nutrition in USD Million
  • Chart 131: Glance at 2021, 2024 and 2030 Rest of World Omega-3 PUFAs Value Market Share (%) by End-use Application - Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition and Clinical Nutrition

Tables

  • Table 1: Types of Polyunsaturated Omega-3 Fatty Acids
  • Table 2: Dietary Sources of Omega-3 Fatty Acids
  • Table 3: Alpha-Linolenic Acid Content of Selected Foods and Oils
  • Table 4: Leading Plant Sources of Alpha-Linolenic Acid (ALA)
  • Table 5: EPA + DHA Content in Selected Fish and Seafood per 85 Gram Serving
  • Table 6: Omega-3 Fatty Acids EPA and DHA in Microalgae
  • Table 7: Forms of Omega-3 Fatty Acid Ingredients
  • Table 8: Microalgae Strains Characterized by EPA Production
  • Table 9: Microalgae Strains Characterized by DHA Production
  • Table 10: Recommendations for Omega-3 Fatty Acids (EPA and DHA) Intake Globally
  • Table 11: Omega-3 Drugs Approved to date
  • Table 12: Omega-3 Drugs Pipeline
  • Table 13: Generic Omega-3 Drugs Approved
  • Table 14: Quality Specifications and Regulations Related to Omega-3 Oils (After Including Data from GOED)
  • Table 15: Early Process Patents Pertaining to Omega-3 Fatty Acids Refining
  • Table 16: Important Patents Pertaining to Processes for the Production of EPA and DHA
  • Table 17: Patents Pertaining to SFE Processes for the Production of EPA and DHA
  • Table 18: Patents Pertaining to Processes for Harvesting Microalgae Strains and Extracting Algal Oil
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!